lipoxin a4 has been researched along with Insulinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bathina, S; Das, UN | 1 |
Das, UN; Gundala, NKV; Naidu, VGM | 1 |
2 other study(ies) available for lipoxin a4 and Insulinoma
Article | Year |
---|---|
PUFAs, BDNF and lipoxin A4 inhibit chemical-induced cytotoxicity of RIN5F cells in vitro and streptozotocin-induced type 2 diabetes mellitus in vivo.
Topics: Alloxan; Animals; Arachidonic Acid; Benzo(a)pyrene; Brain-Derived Neurotrophic Factor; Cell Death; Cell Line, Tumor; Cytotoxins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Doxorubicin; Drug Interactions; Fatty Acids, Unsaturated; Insulin-Secreting Cells; Insulinoma; Lipoxins; Pancreatic Neoplasms; Rats; Rats, Wistar; Streptozocin | 2019 |
Arachidonic acid and lipoxin A4 attenuate alloxan-induced cytotoxicity to RIN5F cells in vitro and type 1 diabetes mellitus in vivo.
Topics: Animals; Apoptosis; Arachidonic Acid; Cell Line, Tumor; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Gene Expression Regulation, Neoplastic; Humans; Insulinoma; Lipoxins; Neoplasm Proteins; Rats | 2017 |